Anti-Proliferative Effects Induced by Anti-CD4 Human/Murine Chimeric Antibody and Murine Anti-CD4 Monoclonal Antibody

被引：0
|
作者：
沈关心
朱慧芬
王晓林
张悦
朱志刚
王硕
机构：
来源：
Journal of Tongji Medical University | 1999年 / 01期
关键词：
CD4; molecule; chimeric antibody; monoclonal antibody; inhibition of proliferation;
D O I：
暂无
中图分类号：
R394-33 [遗传学实验（实验遗传学）、实验方法及设备];
学科分类号：
0710 ; 071007 ;
摘要：
ＣＤ４ｍｏｌｅｃｕｌｅｉｓａｓｐｅｃｉａｌｍａｒｋｅｒｏｆｔｈｅｈｅｌｐｅｒＴｌｙｍｐｈｏｃｙｔｅ（ＴＨ）ａｎｄｄｅｌａｙｅｄｔｙｐｅｈｙｐｅｒｓｅｎｓｉｔｉｖｉｔｙＴｌｙｍｐｈｏｃｙｔｅ（ＴＤＴＨ）ａｓｗｅｌａｓａｄｉｆｅｒｅｎｔｉａｔｉｏｎｍａｒ...
引用
收藏
页码：7 / 10
页数：4
相关论文
共 50 条
  • [41] SUPPRESSION OF ANTIBODY-RESPONSES IN RATS TO MURINE ANTI-CD4 MONOCLONAL-ANTIBODIES BY CONJUGATES WITH MONOMETHOXYPOLYETHYLENE GLYCOL
    LANG, GM
    KIEREKJASZCZUK, D
    RECTOR, ES
    MILTON, AD
    EMMRICH, F
    SEHON, AH
    IMMUNOLOGY LETTERS, 1992, 32 (03) : 247 - 252
  • [42] USE OF OKT4A (A MURINE MONOCLONAL ANTI-CD4 ANTIBODY) IN HUMAN ORGAN-TRANSPLANTATION - INITIAL CLINICAL-EXPERIENCE
    NORMAN, DJ
    BENNETT, WM
    COBANOGLU, A
    HERSHBERGER, R
    HOSENPUD, JD
    MEYER, MM
    MISITI, J
    OTT, G
    RATKOVEC, R
    SHIHAB, F
    VITOW, C
    BARRY, JM
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 802 - 803
  • [43] The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+T-cells in asthma
    Kon, OM
    Sihra, BS
    Loh, LC
    Barkans, J
    Compton, CH
    Barnes, NC
    Larché, M
    Kay, AB
    EUROPEAN RESPIRATORY JOURNAL, 2001, 18 (01) : 45 - 52
  • [44] Human parathyroid grafts survived and functioned in mice treated with anti-CD4 monoclonal antibody
    Niimi, M
    Takashina, M
    Shirasugi, N
    Hamano, K
    Esato, K
    Matsumoto, K
    Ikeda, Y
    Takami, H
    Kodaira, S
    Kameyama, K
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (05) : 1040 - 1040
  • [45] EFFECT OF ANTI-CD4 MONOCLONAL-ANTIBODY ON SURVIVAL OF XENOGRAFTED HUMAN FETAL PANCREAS
    TUCH, BE
    BERETOV, J
    MANDEL, TE
    KOULMANDA, M
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (03) : 2183 - 2184
  • [46] Tolerance to heart and kidney grafts induced by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration
    Motoyama, K
    Arima, T
    Lehmann, M
    Flye, MW
    SURGERY, 1997, 122 (02) : 213 - 219
  • [47] HUMAN ANTI-MOUSE ANTIBODY-RESPONSE INDUCED BY ANTI-CD4 MONOCLONAL-ANTIBODY THERAPY IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    HORNEFF, G
    WINKLER, T
    KALDEN, JR
    EMMRICH, F
    BURMESTER, GR
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1991, 59 (01): : 89 - 103
  • [48] Nondepleting humanized anti-CD4 monoclonal antibody in patients with refractory rheumatoid arthritis
    Moreland, LW
    Haverty, TP
    Wacholtz, MC
    Knowles, RW
    Bucy, RP
    Heck, LW
    Koopman, WJ
    JOURNAL OF RHEUMATOLOGY, 1998, 25 (02) : 221 - 228
  • [49] The effect of humanized anti-CD4 antibody on human haemopoietic progenitors in vitro
    Gilleece, MH
    deWynter, E
    Hoctor, M
    Dougall, M
    Testa, NG
    Dexter, TM
    Fagg, R
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1158 - 1158
  • [50] Zanolimumab - Anti-CD4 monoclonal antibody treatment of T-Cell lymphoma
    Scheinfeld, Noah
    Parish, Daniel H.
    DRUGS OF THE FUTURE, 2007, 32 (08) : 707 - 711
12345